AL158147.2 | HCG2011465; Uncharacterized protein | | | | | | Group enriched |
MMP26 | Matrix metallopeptidase 26 | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enriched |
TEX15 | Testis expressed 15 | | | | | | Group enriched |
MMP10 | Matrix metallopeptidase 10 (stromelysin 2) | Cancer-related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enriched |
PRLHR | Prolactin releasing hormone receptor | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
PAEP | Progestagen-associated endometrial protein | Predicted secreted proteins
| | | | | Group enriched |
MMP11 | Matrix metallopeptidase 11 (stromelysin 3) | Cancer-related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Group enriched |
CHRDL2 | Chordin-like 2 | Predicted secreted proteins
| | | | | Group enriched |
PRL | Prolactin | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
RP4-559A3.7 | Uncharacterized protein | | | | | | Tissue enriched |
ADAMTS19 | ADAM metallopeptidase with thrombospondin type 1 motif, 19 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
FRMD7 | FERM domain containing 7 | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | | Group enriched |
HOXD11 | Homeobox D11 | Cancer-related genes Transcription factors
| | | | | Group enriched |
RP11-763F8.1 | Uncharacterized protein | | | | | | Group enriched |
SLC6A2 | Solute carrier family 6 (neurotransmitter transporter), member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
ZCCHC12 | Zinc finger, CCHC domain containing 12 | | | | | | Group enriched |
FOXL2 | Forkhead box L2 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
SCGB1D2 | Secretoglobin, family 1D, member 2 | Cancer-related genes Predicted secreted proteins
| | | | | Group enriched |
SERTM1 | Serine-rich and transmembrane domain containing 1 | Predicted membrane proteins
| | | | | Group enriched |
SLC46A2 | Solute carrier family 46, member 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
TMEM215 | Transmembrane protein 215 | Predicted membrane proteins
| | | | | Group enriched |
AL162431.1 | Uncharacterized protein | | | | | | Group enriched |
C3orf72 | Chromosome 3 open reading frame 72 | | | | | | Group enriched |
DCX | Doublecortin | Cytoskeleton related proteins Disease related genes
| | | | | Group enriched |
DLX5 | Distal-less homeobox 5 | Disease related genes Transcription factors
| | | | | Group enriched |
DLX6 | Distal-less homeobox 6 | Transcription factors
| | | | | Group enriched |
IGFN1 | Immunoglobulin-like and fibronectin type III domain containing 1 | | | | | | Group enriched |
IHH | Indian hedgehog | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
PTGER3 | Prostaglandin E receptor 3 (subtype EP3) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
RBFOX3 | RNA binding protein, fox-1 homolog (C. elegans) 3 | | | | | | Group enriched |
TRH | Thyrotropin-releasing hormone | Predicted secreted proteins
| | | | | Tissue enriched |
WNT2 | Wingless-type MMTV integration site family member 2 | Cancer-related genes Predicted secreted proteins
| | | | | Group enriched |
AGTR2 | Angiotensin II receptor, type 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
ITGA11 | Integrin, alpha 11 | Predicted membrane proteins
| | | | | Group enriched |
KIAA1644 | KIAA1644 | Predicted membrane proteins
| | | | | Group enriched |
PGR | Progesterone receptor | Cancer-related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Group enriched |
AC006486.9 | Uncharacterized protein | | | | | | Tissue enhanced |
ADRA2C | Adrenoceptor alpha 2C | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ALDH1A2 | Aldehyde dehydrogenase 1 family, member A2 | Enzymes
| | | | | Tissue enhanced |
AP000349.1 | Uncharacterized protein | | | | | | Tissue enhanced |
ASIC2 | Acid-sensing (proton-gated) ion channel 2 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
C1orf186 | Chromosome 1 open reading frame 186 | Predicted membrane proteins
| | | | | Tissue enhanced |
C1orf64 | Chromosome 1 open reading frame 64 | | | | | | Tissue enhanced |
C1QTNF6 | C1q and tumor necrosis factor related protein 6 | | | | | | Tissue enhanced |
CCDC171 | Coiled-coil domain containing 171 | | | | | | Tissue enhanced |
CDH13 | Cadherin 13 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CHURC1-FNTB | CHURC1-FNTB readthrough | | | | | | Tissue enhanced |
CYP24A1 | Cytochrome P450, family 24, subfamily A, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Tissue enhanced |
DPP6 | Dipeptidyl-peptidase 6 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
EMX2 | Empty spiracles homeobox 2 | Disease related genes Transcription factors
| | | | | Tissue enhanced |